IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease
Links shared publicly online about this topic.
- 246total visits
IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease
IDEV Technologies, Inc. today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA stent system for treatment of peripheral artery disease in the superficial femoral artery.
View full resource at news-medical.net
Tags: Circulation, Circulatory Disorders, Peripheral Artery Disease, Thrombotic Event, Disease and Condition, disease
Most Recently Shared on June 3, 2011 at 6:24 am By:
IDEV completes enrollment in SUPERA stent trial for treatment of peripheral artery disease: IDEV Technologies, I... http://bit.ly/ml2VGL
Advertisement
